Ketamine hepato-toxicity in chronic pain management: another example of unexpected toxicity or a predicted result from previous clinical and pre-clinical data?
- PMID: 21555186
- DOI: 10.1016/j.pain.2011.04.031
Ketamine hepato-toxicity in chronic pain management: another example of unexpected toxicity or a predicted result from previous clinical and pre-clinical data?
Comment on
-
Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases.Pain. 2011 Sep;152(9):2173-2178. doi: 10.1016/j.pain.2011.03.026. Epub 2011 May 4. Pain. 2011. PMID: 21546160 Clinical Trial.
References
-
- Baur H, Kasperek S, Pfaff E. Criteria of viability of isolated liver cells. Hoppe Seylers Z Physiol Chem. 1975;356:827-838.
-
- Blunnie WP, Zacharias M, Dundee JW, Doggart JR, Moore J, McIlroy PD. Liver enzyme studies with continuous intravenous anaesthesia. Anaesthesia. 1981;36:152-156.
-
- Boscan P, Pypendop BH, Solano AM, Ilkiw JE. Cardiovascular and respiratory effects of ketamine infusions in isoflurane-anesthetized dogs before and during noxious stimulation. Am J Vet Res. 2005;55:2122-2129.
-
- Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med. 2004;5:263-275.
-
- Dundee JW, Fee JP, Moore J, McIlroy PD, Wilson DB. Changes in serum enzyme levels following ketamine infusions. Anaesthesia. 1980;35:12-16.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical